Document is current
Any future updates will be listed below
-
Authors
Loubet, Paul https://orcid.org/0000-0002-1218-9432
Benotmane, Ilies https://orcid.org/0000-0001-9113-2479
Fourati, Slim
Malard, Florent https://orcid.org/0000-0002-3474-0002
Vuotto, Fanny
Blanchard, Elodie https://orcid.org/0000-0001-5445-9122
Raffi, François
Nguyen, Stéphanie
de Prost, Nicolas https://orcid.org/0000-0002-4833-4320
Avouac, Jérôme
- License Information
-
More Information
Article History
Received: 20 January 2025
Accepted: 25 February 2025
First Online: 18 March 2025
Declarations
:
: Paul Loubet has received payment or honoraria for lectures, presentations, speakers’ bureaus, manuscript writing, or educational events from AstraZeneca, GSK, Janssen, MSD, Moderna, Pfizer, Sanofi Pasteur, and Seqirus. Ilies Benotmane has received speaker fees from AstraZeneca, Biotest, and MSD; and has participated in advisory boards for Chiesi, MSD, and Takeda. Slim Fourati has served as a speaker for AstraZeneca, Cepheid, GSK, Moderna, MSD, Pfizer, and Sanofi; and has received grant funding from Moderna. Florent Malard has received honoraria from AstraZeneca, Bristol Myers Squibb, Gilead, Jazz Pharmaceuticals, MSD, Novartis, Sanofi, and Therakos/Mallinckrodt. Fanny Vuotto has served as an advisor for Takeda. Elodie Blanchard has received payment or honoraria for presentations or expert advice from AstraZeneca, Boehringer Ingelheim, Chiesi, Gilead, GSK, Janssen, MSD, Pfizer, Sanofi, and SOS Oxygène. François Raffi has served as an advisor and/or speaker for AstraZeneca, Moderna, and Roche. Stéphanie Nguyen has received honoraria from AbbVie, AstraZeneca, Gilead, Jazz Pharmaceuticals, Medac, Neovii, Novartis, and Sanofi. Nicolas de Prost has served as an advisor and/or speaker for AstraZeneca and Moderna. Jérôme Avouac has served as a speaker for AstraZeneca.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.
